Bruton’s tyrosine kinase inhibitors and their clinical potential in the treatment of B-cell malignancies: focus on ibrutinib

Por Aalipour, Amin, Advani, Ranjana H.
Publicado em 2014

Bruton tyrosine kinase inhibitors: a promising novel targeted treatment for B cell lymphomas

Por Aalipour, Amin, Advani, Ranjana H.
Publicado no Br J Haematol (2013)

Molecular profiling of single circulating tumor cells from lung cancer patients

Por Park, Seung-min, Wong, Dawson J., Ooi, Chin Chun, Kurtz, David M., Vermesh, Ophir, Aalipour, Amin, Suh, Susie, Pian, Kelsey L., Chabon, Jacob J., Lee, Sang Hun, Jamali, Mehran, Say, Carmen, Carter, Justin N., Lee, Luke P., Kuschner, Ware G., Schwartz, Erich J., Shrager, Joseph B., Neal, Joel W., Wakelee, Heather A., Diehn, Maximilian, Nair, Viswam S., Wang, Shan X., Gambhir, Sanjiv S.
Publicado no Proc Natl Acad Sci U S A (2016)